Navigation Links
AAD Warns Against Indoor Tanning for the Holiday Season

in the news have suggested that vitamin D may help a person reduce his or her risk for cancer and other diseases.

“Because vitamin D can be produced through exposure to UV light, some people may think that they have to have exposure to the sun or a tanning lamp to produce optimal amounts of the nutrient,” Dr. Kauvar said. “But there are safe ways to get vitamin D each day – drinking a couple of glasses of vitamin D-fortified milk or orange juice, eating salmon or mackerel and other foods rich in vitamin D, or taking a supplement – that do not pose a health risk like tanning does.”

To help people, particularly teen girls, understand the risks of indoor tanning, the Academy recently produced a public service advertisement campaign (PSA) about this issue.

The Academy’s 2006 – 2007 skin cancer PSA campaign speaks to teens in a language they can understand, instant messaging (IM). Approximately 53 million American computer users – most of them teens – use IMs. Many exchange IMs more frequently than e-mail. It has a language all its own, and the Academy has developed this campaign specifically for teens who use it.

This aggressive campaign consists of television, radio and print advertisements that highlight the risks of skin cancer and skin damage which indoor tanning can cause.

“The Academy is committed to leading the charge to reduce mortality from and the incidence of skin cancer in the next 10 to 30 years,” said Dr. Kauvar. “Through this PSA campaign, we are targeting a critical age group to help motivate them to avoid this risky activity entirely and help reduce the skin cancer statistics.”

Surce-Newswise
SRM
'"/>




Page: 1 2

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
3. ADB Report Warns of Bird-Flu Catastrophe
4. FDA Warns Against Birth-Control Patch
5. Charlotte Church Warns kiss n tell girls not to flirt with Henson
6. UK Committee Warns on Food Shortages Due to Flu Epidemic
7. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
8. Bishop Warns Against Change in Mercy Killing Laws
9. Manitoba Ombudsman Warns Pharmacists
10. FDA Warns VaxGen On Anthrax Vaccine
11. Doctors In New Zealand Warns Against Using Ayurveda Medicines
Post Your Comments:
(Date:12/1/2008)... EXTON, Pa., Dec. 1 Vir...unced that the company submitted a supplemental,B...od and Drug Administration,(FDA) for Cinryze(TM) ...cks of,hereditary angioedema (HAE). , The ... data from a pivotal,Phase 3 acute treatment stud...
(Date:12/1/2008)... Alcohol, nicotine use, personality illnesses com...althDay News) -- Psychiatric disorders are common ...eek treatment, a new report shows. , To reach t...ore than 5,000 respondents, aged 19 to 25, who too...ohol and Related Conditions. , The study found ...
(Date:12/1/2008)... , A new analysis of the National Cancer Institut...in five older women experience delayed or incomple... surgery, and that this suboptimal care can lead t...eill Cornell Medical College and colleagues found ...early 8,000 breast cancer registry patients aged 6...
(Date:12/1/2008)... WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- ...e release of a model state legislative resolution ...). AUL urges state legislatures to adopt the reso...ssions. , , Dr. Charmaine Yoest, AUL Presid...ice Act, endangers women,s health. It protects an...
Breaking Medicine News(10 mins):Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...k we had carried a story about Wal-mart’s foray in... a pilot project which involved the lease of medic... 76 clinics actively functioning at the Wal mart s...uring the meeting of the 4th Annual World Health C...
...nd busier an NHS hospital is, the higher the MRSA ...versity Business School has revealed. The impact...MRSA infections in NHS hospitals study looked at h... imposed by hospital insurers — and the premium di...
...st vaccination of sixth-grader girls to prevent ce...-Texas Governor Rick Perry. //The move sees that T...ixth-grade girls to be vaccinated against a sexual...al cancer. Yesterday, the Texas House gave the go...
...bility and resources for public health and tacklin...cils rather than with the NHS, argues an expert in...m University says that partnerships between local ...d then become a true meeting of the two sides of h...
Other Medicine News:Health News:Better Risk Management Could Cut MRSA Infection Rates 2Health News:Local Councils Should Be Responsible for Tackling Health Inequalities 2
(Date:12/1/2008)...uled for Tuesday, December 9 at 11:00 am ET to Dis...OUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-F...: SNSS ), a biopharmaceutical company focused on...logy therapeutics, today announced new data from i...(AML) will be presented during the 50th American S...
(Date:11/28/2008)...ovember 28 German biotech company,...ialized HIV monitoring and,AIDS patient follow-up.... In,the year 2008, 2.5 million patient tests hav...ghly affordable "CyFlow" system, supporting alread.... Due to introduction of the,Partec innovation, t...
(Date:11/26/2008)...bjects , , FRANKLIN, Mass., Nov. 26 /PRNews...Board: PLCSF) announced today that it has received...tration (FDA) for its U.S. pivotal trial to study ...em(TM) and associated therapy in the prevention o...he FDA also approved PLC,s request to expand their...
(Date:11/25/2008)...if., Nov. 25 Poniard,Ph...ceutical company focused on,innovative oncology t...g,strategic alternatives for its preclinical rese...cus its resources on the clinical development of p...port the initial commercialization of,picoplatin ...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Liver Transplant Patients at Higher Cancer Risk 27261 1Liver Transplant Patients at Higher Cancer Risk 27261 2PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 8212 1PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 8212 2Hologic Inc To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday November 11 2008 27255 1Hologic Inc To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday November 11 2008 27255 2Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 27252 1Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 27252 2
...ournal of Clinical Oncology -, NEW YORK, July 06, ...e II study - which will be published in the August...y (JCO) and are now,available as an Early Release ...o.org/">www.jco.org - demonstrate that,ixabepilon...compound, has activity in patients with metastatic...
...5, an Investigational NNRTI,from Tibotec, YARDLEY,...ongoing Phase 3 studies (DUET-1 and DUET-2) showed...mented non-nucleoside reverse,transcriptase inhibi... reached an undetectable viral load (defined as ac...A copies/mL) with,TMC125 (etravirine), Tibotec,s i...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
11.5 mm curved hook. Flat serrated handle with polished finish. Overall length: 5.9 inches.
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall
0.2 mm Sinskey hook with shaft angled 45 degrees, 10 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches.
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches.
Medicine Products: